Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.116 SEK | -7.00% |
|
-7.77% | +61.97% |
06-26 | Alligator Bioscience Announces Results from the Ongoing Optimize-1 Trial | CI |
06-20 | Alligator Bioscience AB to Present Positive Phase 2 Data on Mitazalimab in Pancreatic Cancer at ESMO GI 2024 | CI |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe![Consensus](/images/consensus_flch.gif)
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+61.97% | 85.82M | |
+16.59% | 45.51B | |
-9.89% | 38.52B | |
+38.08% | 38.13B | |
+27.12% | 30.74B | |
-8.64% | 26.03B | |
+11.81% | 25.92B | |
+45.08% | 14.13B | |
+32.85% | 12.73B | |
-7.19% | 11.29B |
- Stock Market
- Equities
- ATORX Stock
- News Alligator Bioscience AB
- Transcript : Alligator Bioscience AB, Q3 2020 Earnings Call, Oct 22, 2020